Isabel Salcedo de Diego

Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

A. Fernández-Cruz, R. M. de Molina, J. Bueno, 2021, Trials.

Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

A. Fernández-Cruz, R. M. de Molina, J. Bueno, 2020, Trials.

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

J. Rubio, R. M. de Molina, R. Sánchez, 2021, Trials.